Login
Navigate Fool.com
Will ONTX beat
the market?
Community Rating: 3 Stars: Appealing

5.70 0.03 (0.53%)

Quote as of

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $5.69
Previous Close $5.67
Daily Range $5.62 - $5.95
52-Week Range $5.25 - $31.13
Market Cap $123.3M
P/E Ratio -0.93
Dividend (Yield) $0.00 (0.0%)
Volume 200,910
Average Daily Volume 304,540
Current FY EPS -$2.09

How do you think ONTX
will perform against the market?

Top ONTX Bull/Bear Pitches

 

There are no pitches that meet the Top Bull criteria. Explain

If this upsets you, start recommending pitches here!

 

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches here!

News & Commentary Rss Feed

This Week in Biotech: Buyouts, an FDA Approval, and Clinical Data. Oh, My!

A $25 billion buyout, a long-awaited FDA approval, two positive clinical studies, and one biopharma losing 37% of its value, are this week's top biotech stories.

3 Horrendous Health-Care Stocks This Week

Which health-care stocks experienced the agony of defeat this week?

Why Onconova Therapeutics Inc. Shares Imploded

Onconova Therapeutics reported disappointing phase 3 results for high-risk myelodysplastic syndrome drug rigosertib. Is this sell-off a buying opportunity or a reason to leave and not turn back?

Stocks: Insiders Buy at General Electric and American Eagle

Plus, purchases at Selectica and Onconova.

Why Jabil Circuit, Inc., Onconova Therapeutics Inc., and Gogo Inc. Plunged Today

The long-awaited move from the Federal Reserve to cut back on its quantitative easing sent the markets roaring higher, but among the few decliners today, Jabil Circuit dropped almost 21%, Onconova Therapeutics fell 19%, and Gogo declined 16%. Find out why these stocks didn't join in the Fed-induced celebration Wednesday.

Why Onconova Therapeutics Inc. Shares Crashed

Onconova discontinues a late-stage trial for its lead experimental drug. Is this a classic overreaction by emotional traders or a reason to avoid Onconova?

Keep an Eye on Onconova, Enzymotec, DepoMed, and Omeros Today

Onconova, Enzymotec, DepoMed, and Omeros could make health care headlines this morning. Here’s why.

See More ONTX News...

Sector

Industry

ONCONOVA THERAPEUTICS INC (ONTX) Description

ONCONOVA THERAPEUTICS INC Website: http://www.onconova.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks